Evaluation of biosimilarity of RinGlar® (GEROPHARM LLC, Russia) and Lantus® (Sanofi-Aventis Deutschland GmbH, Germany) using the euglycemic hyperinsulinemic clamp technique in patients with type 1 diabetes: double-blind randomized clinical trial [PDF]
, 2020 Background: Prevention of the development of micro-and macrovascular complications in patients with diabetes melli-tus (DM) encouraged the search for insulin analogues that allow imitating, as close as possible, a normal physiological insulin secretion ...
Alexander Y. Mayorov +8 more
core +1 more source
Modern antihyperglycemic agents prescribed in Russia for type 2 diabetes mellitus [PDF]
, 2012 Aims. To conduct an analysis of modern antihyperglycemic prescription patterns in type 2 diabetes mellitus (T2DM). Materials and methods. Russian DM State registry was studied. Results.
Yury Ivanovich Suntsov
core +3 more sources
Characteristics of natural history of diabetes mellitus, manifested after Cushing disease treatment [PDF]
, 2012 We report a case of diabetes mellitus, manifested against the background of hormone replacement therapy after treatment of ...
Elena Viktorovna Peretokina +3 more
core +3 more sources
Enzyme-Linked Immunosorbent Assay Method Application in the Study of Comparative Pharmacokinetics of Insulin Glargin Preparations [PDF]
, 2019 Aims: adaptation and validation of the ELISA method insulin glargine determination for the pharmacokinetic study, practical approval in the biosimilars clinical trial.Materials and methods.
A. A. Abramova +9 more
core +2 more sources
Study of the condition and problems of providing diabetes patients with insulin preparations and means of glycemia monitoring [PDF]
, 2023 DM is a global medico-social problem, characterized by threatening trends in the spread and development of complications. One of the key elements of the system of effective treatment of DM is the continuous supply of patients with hypoglycemic ...
A. S. Nemchenko +2 more
core +2 more sources
Health technology assessement of the fxed combination of insulin glargine 100 UI/ml and lixisenatide in the treatment intensifcation of diabetes mellitus type 2 [PDF]
, 2019 Fixed antidiabetic drugs’ combinations have aim to improve of Diabetes Mellitus type 2 (DMT2) control as well as a safety treatment increasing. Soliqua SoloStar® is a new registered drug for control of fasting and prandial glucose levels, contained ...
I. N. Dyakov, S. К. Zyryanov
core +2 more sources
Встановлення структур білку при доведенні біосимілярності біофармацевтичних препаратів білкової природи [PDF]
, 2021 Робота публікується згідно наказу Ректора НАУ від 27.05.2021 р. №311/од "Про розміщення кваліфікаційних робіт здобувачів вищої освіти в репозиторії університету" . Керівник проекту: доцент, к. ф.-м. н. Чубко Л.С.Зроблений порівняльний аналіз оригінальних
Савченко, Марія Олександрівна
core
Economic perspectives for effective control of diabetes mellitus type 2 with fixed combination of basal insulin analog and GLP-1 agonist [PDF]
, 2019 Fixed antidiabetic drugs’ combinations have aim to improve Diabetes Mellitus type 2 (DMT2) control as well as a safety treatment increasing. Soliqua SoloStar® is a new registered drug for control fasting and prandial glucose levels, contained insulin ...
I. N. Dyakov, S. K. Zyryanov
core +2 more sources
, 2009 ФАРМАКОЛОГИЯУчебно-методическое пособие включает в себя 46 тем.
Гриб, Н. М. +5 more
core +1 more source